Based on these observations, SH2B3, SF3B1, U2AF1, TP53, IDH2, and EZH2 were included as adverse mutations in ET and ASXL1, SRSF2, and IDH2 as adverse mutations in PV. This evidence concerns the gene ASXL1 and essential thrombocythemia.